See also this year's filing and all EDGAR filings for this company.
PDF Report 0001322505_2021_Albireo_Pharma_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001322505, Albireo Pharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 261,865,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 17,260,000 |
| 2 | PropertyPlantAndEquipmentNet | 478,000 |
| 3 | remainder_Assets | 6,004,000 |
| 4 | LiabilitiesCurrent | 25,282,000 |
| 5 | LiabilitiesNoncurrent | 3,579,000 |
| 6 | remainder_Liabilities | 75,515,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 55,199,488 |
| 9 | ResearchAndDevelopmentExpense | 204,296,844 |
| 10 | remainder_Expenses | 530,396 |
| 11 | remainder_Revenues | 8,970,872 |
| 12 | remainder_NetIncome | -6,831,444 |
| 13 | remainder_ComprehensiveNetIncome | -36,195,570 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 285,607,000 |
| 1 | Liabilities | 104,376,000 |
| 2 | Expenses | 260,026,728 |
| 3 | Revenues | 8,970,872 |
| 4 | StockholdersEquity | 181,231,000 |
| 5 | NetIncome | -257,887,300 |
| 6 | ComprehensiveNetIncome | -275,985,085 |
| 7 | BaseVar | 351,003,807 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.611 |
| 9 | EconomicCapitalRatio | 1.98 |
Edgar->Model Mapping
Feature Distribution
Change over Time
